Nuvectis Pharma, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.95 | $56.28 M | -5.86 | 2 | $0 |
 AVTE
|
Aerovate Therapeutics, Inc. | $2.04 | $597.48 M | -6.84 | 51 | $0 |
 CCCC
|
C4 Therapeutics, Inc. | $5.40 | $320.64 M | -1.97 | 145 | $20.76 M |
 CELC
|
Celcuity Inc. | $15.04 | $501.59 M | -5.14 | 55 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $16.32 | $1.29 B | -7.16 | 85 | $0 |
 CMPX
|
Compass Therapeutics, Inc. | $1.93 | $180.24 M | -3.74 | 32 | $0 |
 CNTA
|
Centessa Pharmaceuticals plc | $15.92 | $884.24 M | -6.2 | 72 | $6.88 M |
 DBTX
|
Decibel Therapeutics, Inc. | $4.91 | $123.37 M | -1.93 | 68 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $28.40 | $1.65 B | -11.47 | 97 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.10 | $243.38 M | -1.59 | 129 | $0 |
 GOSS
|
Gossamer Bio, Inc. | $1.07 | $124.06 M | -0.65 | 135 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $2.02 | $151.66 M | -3.17 | 45 | $19.94 M |
 IKNA
|
Ikena Oncology, Inc. | $1.70 | $84.45 M | -1.11 | 18 | $9.16 M |
 IVA
|
Inventiva S.A. | $1.87 | $185.39 M | -1.34 | 120 | $17.48 M |
 KRON
|
Kronos Bio, Inc. | $0.97 | $44.62 M | -0.37 | 58 | $6.29 M |
 LRMR
|
Larimar Therapeutics, Inc. | $6.62 | $611.84 M | -9.99 | 42 | $0 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.24 | $19.53 M | -0.27 | 88 | $1.56 M |
 NAMS
|
NewAmsterdam Pharma Company N.V. | $18.22 | $1.74 B | -7.15 | 57 | $12.76 M |
 OBIO
|
Orchestra BioMed Holdings, Inc. | $4.91 | $285.59 M | -5.47 | 56 | $2.76 M |
 OLMA
|
Olema Pharmaceuticals, Inc. | $11.56 | $734.41 M | -6.56 | 80 | $0 |
 REPL
|
Replimune Group, Inc. | $11.48 | $485.18 M | -2.44 | 331 | $0 |